Dr Josef Witt-Doerring Scandal Behind SSRIs & Post-SSRI Sexual Dysfunction

Dr. Josef Witt-Doerring Exposes the Hidden Scandal Behind SSRIs and Post-SSRI Sexual Dysfunction

A growing medical scandal may be one of the most underreported stories of our time.
Psychiatrist Dr. Josef Witt-Doerring has raised the alarm over a devastating condition linked to antidepressants known as Post-SSRI Sexual Dysfunction (PSSD)—a permanent form of sexual, emotional, and cognitive blunting that persists even after stopping the medication.

According to Witt-Doerring, roughly 70% of SSRI users experience sexual side effects like erectile dysfunction, loss of libido, and muted pleasure. But the real tragedy emerges for the estimated 1 in 216 who never recover.
These patients describe genital anesthesia, total loss of erogenous sensation, emotional numbness, and brain fog so severe it feels like being “lobotomized.”

Witt-Doerring calls it a betrayal of medical trust. Regulators in Europe, Canada, Australia, and Hong Kong have already updated drug labels to warn about this risk—yet the U.S. FDA has refused to act, despite receiving the same scientific dossier over six years ago.

A citizen’s petition demanding a warning label was filed in 2018. The FDA ignored it. When advocates sued, the agency dismissed the case on a technicality. Meanwhile, millions of Americans continue taking these drugs without informed consent about potentially permanent side effects.

Dr. Witt-Doerring believes the silence is deliberate: “The FDA is protecting pharmaceutical interests, not the public.”
He remains hopeful that under President Trump’s administration and Secretary Kennedy’s leadership, long-suppressed issues like PSSD will finally be addressed.

Both conservative and liberal media now appear to be turning on Big Pharma’s psychiatric establishment—signaling what could be a historic reckoning.

The question remains:
How many lives have to be quietly ruined before U.S. regulators admit what the rest of the world already has?